Clinical Trials in Arizona

Showing 8941-8960 of 16,770 trials

Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain

NCT04166045

Clinical study to determine the responder rate of the TheraNova Migraine Treatment System to that of a sham control treatment.

Episodic Migraine

Theranova, L.L.C.20 participantsStarted Jun 2020

Scottsdale, Arizona, United States

COMPLETEDPhase 135 miles

A Study to Compare the Relative Bioavailability of Two AG-881 Formulations and Evaluate the Effect of Food and Omeprazole on the Pharmacokinetics of AG-881

NCT04128787

The purpose of this study is to compare the single-dose pharmacokinetics (PK) of two formulations (Formulation 1 and Formulation 2) of AG-881 and to examine the effect of food and multiple-dose omeprazole on the single-dose PK of AG-881 Formulation 2 in healthy adult participants. This study will also assess the safety and tolerability of single-dose AG-881 (Formulation 1 and 2) alone and of AG-881 Formulation 2 when administered with and without food and when coadministered with omeprazole in healthy adult subjects.

Healthy Volunteers

Agios Pharmaceuticals, Inc.36 participantsStarted Sep 2019

Tempe, Arizona, United States

COMPLETEDPhase 342 miles

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

NCT02307513

The main objective of this study is to evaluate the efficacy and safety of apremilast in the treatment of oral ulcers in adults with active Behçet's disease (BD).

Behçet's Syndrome

Amgen207 participantsStarted Dec 2014

Phoenix, Arizona, United States • Sacramento, California, United States • Ormond Beach, Florida, United States +60 more locations

Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain

A Study to Compare the Relative Bioavailability of Two AG-881 Formulations and Evaluate the Effect of Food and Omeprazole on the Pharmacokinetics of AG-881

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

Find Trials by Condition in Arizona

Scoring System for Inhalation Injury

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Prospective US Radiofrequency SUI Trial

Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia